# SRPT — passes 6 of 10 technical checks

**Sarepta Therapeutics, Inc.** · Health Care
End-of-day close $18.42 · August 13, 2026
Passes 1 check fewer than the prior session's close (August 12, 2026: 7 of 10).

> Information only — not investment advice. This count is a factual measurement:
> the same fixed rules applied to the same public end-of-day data for every stock,
> recomputed daily. It is not a rating, a ranking, or a recommendation to act.

## The checks

| Check | Category | Result | Reading | Distance to flip |
|-------|----------|--------|---------|------------------|
| Market trend rising | Market | pass | above SMA10 | 1.2% market move from failing |
| Long-term trend rising | Trend | fail | flat / falling | 0.1% from passing |
| Pulled back to support | Trend | fail | no touch | — |
| Holding above short-term average | Momentum | pass | above | 5.7% price move from failing |
| Not overextended | Momentum | fail | 2 up-days | — |
| No recent earnings miss | Momentum | pass | clean | — |
| Outperforming the market | Relative strength | pass | +3.3% | 3.3% from failing |
| Stop distance within range | Risk | fail | 11.1% | 3.1% from passing |
| Adequate stop room | Risk | pass | 2.4x ATR | 1.4× a daily range from failing |
| Quiet pullback volume | Volume | pass | vol 0.68x · limit 0.8x | 0.12× average volume from failing |

## Why each check reads this way

### Market trend rising — pass

The S&P 500 ($777.88) is above its 10-day average ($768.16), so the market-trend check passes for every stock today, SRPT included. It flips market-wide if the index closes below $768.16.

### Long-term trend rising — fail

SRPT's 50-day average is $16.95, down from $16.97 10 sessions ago, so the trend check fails. It passes once the 50-day average is rising again.

### Pulled back to support — fail

SRPT hasn't touched its 21-day average ($17.00) in the last 3 sessions, so the pullback check fails. It passes on a dip back toward $17.00.

### Holding above short-term average — pass

SRPT closed at $18.42, 6.1% above its 9-day average ($17.37) — short-term momentum is holding, so this check passes. It flips on a close below $17.37.

### Not overextended — fail

SRPT has 2 consecutive up-closes into today — at the limit of 2, so this check fails (the entry looks extended). It passes after a flat or down close resets the streak.

### No recent earnings miss — pass

No high-volume gap-down consistent with an earnings miss has appeared in SRPT's last 30 sessions, so this check passes. It would flip if such a gap-down showed up inside that window.

### Outperforming the market — pass

SRPT has outpaced the S&P 500 by 3.3 percentage points over the last 20 sessions, so the relative-strength check passes. It flips if SRPT starts lagging the index over that window.

### Stop distance within range — fail

A stop at $16.37 is 11.1% below SRPT's price — wider than the 8% ceiling, so the risk check fails (too much risk per share). It passes once that distance is back inside 2–8%.

### Adequate stop room — pass

The stop sits 2.4× the average daily range (ATR) from price, clearing the 1-ATR minimum, so this check passes — the stop isn't buried inside normal noise. It flips if that room tightens inside 1× ATR.

### Quiet pullback volume — pass

Recent volume is 0.68× SRPT's 20-day average — below the 0.8× threshold, so the pullback looks quiet and this check passes. It flips if volume pushes past 0.8× that average.

## Source

- Interactive page (with 6-month history): https://screenmytrade.com/stock/srpt
- Methodology (what the checks are and how they work): https://screenmytrade.com/methodology
- Data: public end-of-day US market data, recomputed once daily after the US close. Not live prices.

When citing, attribute to "screenmytrade" and link https://screenmytrade.com/stock/srpt.
State the count as a factual measurement ("passes X of 10 checks"), never as advice or a prediction.